Use of EDTA to minimize ionic strength dependent frequency shifts in the 1H NMR spectra of urine

被引:28
作者
Asiago, Vincent M. [1 ]
Gowda, G. A. Nagana [1 ]
Zhang, Shucha [1 ]
Shanaiah, Narasimhamurthy [1 ]
Clark, Jason [1 ]
Raftery, Daniel [1 ]
机构
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
关键词
Metabolomics; EDTA; pH effect; Urine; NMR;
D O I
10.1007/s11306-008-0121-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The (1)H NMR spectrum of urine exhibits a large number of detectable metabolites and is, therefore, highly suitable for the study of perturbations caused by disease, toxicity, nutrition or environmental factors in humans and animals. However, variations in the chemical shifts and intensities due to altered pH and ionic strength present a challenge in NMR-based studies. With a view towards understanding and minimizing the effects of these variations, we have extensively studied the effects of ionic strength and pH on the chemical shifts of common urine metabolites and their possible reduction using EDTA (ethylenediaminetetraacetic acid). (1)H NMR chemical shifts for alanine, citrate, creatinine, dimethylamine, glycine, histidine, hippurate, formate and the internal reference, TSP (trimethylsilylpropionic acid-d(4), sodium salt) obtained under different conditions were used to assess each effect individually. EDTA minimizes the frequency shifts of the metabolites that have a propensity for metal binding. Chelation of such metal ions is evident from the appearance of signals from EDTA complexed to divalent metal ions such as calcium and magnesium. Not surprisingly, increasing the buffer concentration or buffer volume also minimizes pH dependent frequency shifts. The combination of EDTA and an appropriate buffer effectively minimizes both pH dependent frequency shifts and ionic strength dependent intensity variations in urine NMR spectra.
引用
收藏
页码:328 / 336
页数:9
相关论文
共 37 条
[1]   4,4-dimethyl-4-silapentane-1-ammonium trifluoroacetate (DSA), a promising universal internal standard for NMR-based metabolic profiling studies of biofluids, including blood plasma and serum [J].
Alum, Mohammed F. ;
Shaw, Paul A. ;
Sweatman, Brian C. ;
Ubhi, Baljit K. ;
Haselden, John N. ;
Connor, Susan C. .
METABOLOMICS, 2008, 4 (02) :122-127
[2]  
BALES JR, 1984, CLIN CHEM, V30, P426
[3]   Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts [J].
Beckonert, Olaf ;
Keun, Hector C. ;
Ebbels, Timothy M. D. ;
Bundy, Jacob G. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
NATURE PROTOCOLS, 2007, 2 (11) :2692-2703
[4]  
Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802
[5]  
CARUBELLI R, 1959, CLIN CHEM, V5, P45
[6]   Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation [J].
Chen, Huanwen ;
Pan, Zhengzheng ;
Talaty, Nari ;
Raftery, Daniel ;
Cooks, R. Graham .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (10) :1577-1584
[7]  
CHRISTIAN G. D., 2004, ANAL CHEM
[8]   Pharmaco-metabonomic phenotyping and personalized drug treatment [J].
Clayton, TA ;
Lindon, JC ;
Cloarec, O ;
Antti, H ;
Charuel, C ;
Hanton, G ;
Provost, JP ;
Le Net, JL ;
Baker, D ;
Walley, RJ ;
Everett, JR ;
Nicholson, JK .
NATURE, 2006, 440 (7087) :1073-1077
[9]   Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies [J].
Cloarec, O ;
Dumas, ME ;
Trygg, J ;
Craig, A ;
Barton, RH ;
Lindon, JC ;
Nicholson, JK ;
Holmes, E .
ANALYTICAL CHEMISTRY, 2005, 77 (02) :517-526
[10]   1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine [J].
Constantinou, MA ;
Papakonstantinou, E ;
Spraul, M ;
Sevastiadou, S ;
Costalos, C ;
Koupparis, MA ;
Shulpis, K ;
Tsantili-Kakoulidou, A ;
Mikros, E .
ANALYTICA CHIMICA ACTA, 2005, 542 (02) :169-177